Medication Therapy Management (MTM) programs were included as a quality-improvement requirement under the Medicare Modernization Act of 2003 to improve medication use and outcomes and reduce the risk of adverse events. However, the current MTM program does not offer Part D sponsors financial incentives to provide comprehensive MTM programs or to drive beneficiaries’ participation in MTM service offerings.
IMPAQ is helping the Centers for Medicare & Medicaid Services (CMS) implement a new performance-based payment model, providing technical implementation support services prior to and during the five-year Part D Enhanced MTM Model test. This includes data collection, analysis, and performance monitoring of participants (stand-alone Part D plans in five US regions). Specifically, we are:
Our team, made up of managing directors, project managers, senior researchers, analysts, and specialized programmers, includes experts in pharmaceutical health services delivery, CMS program implementation, MTM, quality measurement, and Medicare data analysis within CMS data systems.